KAZIMI A J 13D and 13G filings for Cumberland Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 5:26 pm Sale |
2025-02-13 | 13G | Cumberland Pharmaceuticals Inc. CPIX |
KAZIMI A J | 5,702,296 40.800% |
-51,062 (-0.89%) |
Filing |
| 2023-02-10 5:01 pm Sale |
2022-12-31 | 13G | Cumberland Pharmaceuticals Inc. CPIX |
KAZIMI A J | 5,753,358 39.410% |
-17,205 (-0.30%) |
Filing |
| 2022-02-14 5:17 pm Purchase |
2021-12-31 | 13G | Cumberland Pharmaceuticals Inc. CPIX |
KAZIMI A J | 5,770,563 38.330% |
227,218 (+4.10%) |
Filing |